IN2014MN01484A - - Google Patents

Info

Publication number
IN2014MN01484A
IN2014MN01484A IN1484MUN2014A IN2014MN01484A IN 2014MN01484 A IN2014MN01484 A IN 2014MN01484A IN 1484MUN2014 A IN1484MUN2014 A IN 1484MUN2014A IN 2014MN01484 A IN2014MN01484 A IN 2014MN01484A
Authority
IN
India
Prior art keywords
composition
ingredients
insulin
acylated
level
Prior art date
Application number
Other languages
English (en)
Inventor
Artur Viktorovich Martynov
Boris Slavinovich Farber
Sofya Borisovna FARBER
Original Assignee
Artur Viktorovich Martynov
Boris Slavinovich Farber
Sofya Borisovna FARBER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artur Viktorovich Martynov, Boris Slavinovich Farber, Sofya Borisovna FARBER filed Critical Artur Viktorovich Martynov
Publication of IN2014MN01484A publication Critical patent/IN2014MN01484A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1484MUN2014 2011-12-28 2011-12-28 IN2014MN01484A (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2011/001061 WO2013100793A1 (ru) 2011-12-28 2011-12-28 Производное инсулина, обладающее сахароснижающей активностью, и способ его получения

Publications (1)

Publication Number Publication Date
IN2014MN01484A true IN2014MN01484A (ru) 2015-05-01

Family

ID=48698085

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1484MUN2014 IN2014MN01484A (ru) 2011-12-28 2011-12-28

Country Status (3)

Country Link
EA (1) EA023447B1 (ru)
IN (1) IN2014MN01484A (ru)
WO (1) WO2013100793A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202090763A1 (ru) * 2017-11-15 2020-08-03 Борис Славинович ФАРБЕР Фармацевтическая композиция для стимуляции деления стволовых клеток и подавления вирулентности бактерий

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530450A (en) * 1999-11-05 2004-06-25 Emisphere Tech Inc Phenoxy carboxylic acid compounds and compositions for delivering active agents
EP2370059A1 (en) * 2008-11-28 2011-10-05 Novo Nordisk A/S Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides

Also Published As

Publication number Publication date
WO2013100793A1 (ru) 2013-07-04
EA023447B1 (ru) 2016-06-30
EA201300207A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
AR077484A1 (es) Formulacion de acetato de glatiramer de volumen reducido y metodos para su administracion
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
RU2012102322A (ru) Композиции и способы улучшения медикаментозной терапии средствами, зависящими от ионов металлов
JP2011241213A5 (ru)
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
MX349176B (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
WO2010129138A3 (en) Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
EA200901112A1 (ru) Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу
MX336657B (es) Prevencion de hipoglucemia en pacientes con diabetes sacarina de tipo 2.
WO2011116139A3 (en) Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
WO2006120574A3 (en) Analogs of 4-hydroxyisoleucine and uses thereof
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
JP2016539921A5 (ru)
CA2982645C (en) Composition for suppressing muscular fatty change
CA2889109C (en) Composition comprising citrulline and citicoline for improving decline in brain function
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
EA201391063A1 (ru) Аполипопротеин a-iv в качестве антидиабетического пептида
US20100119499A1 (en) Stilbene-based compositions and methods of use therefor
WO2011128782A3 (en) Compositions and methods for treating type ii diabetes and related disorders
IN2014MN01484A (ru)
Vadivelan et al. The'golden hour'in paraquat poisoning
JP2007031302A (ja) アディポネクチン産生促進剤、及び代謝異常症候群予防剤
Das et al. Effects of resveratrol on oxidative stress in high fat diet/streptozocin induced diabetic wistar albino rats
JP2020100601A (ja) 一酸化窒素合成酵素活性化剤
Chou et al. Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine